BRAUSETABLETTEN, ENTHALTEND ALENDRONAT
European patent · EP1490024 · Deleted
Register entry
- Publication number
- EP1490024
- Application number
- EP03716287
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- Deleted
- Specification
- Granted
- Filed
- Mar 6, 2003
- Published
- Dec 29, 2004
- Granted
- Jan 18, 2012
- Deleted
- Mar 6, 2023
- Reason
- Maximum term reached
- IPC classes
- A61K 31/663 (2006.01)A61K 9/46 (2006.01)
- Priority
- US 92083 06.03.2002
- PCT application
- PCT/US2003/006576 06.03.2003
- PCT publication
- WO2003/075884 18.09.2003
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Mar 6, 2023
Maximum term reached
Published in Swissreg on 06.03.2023
- Feb 3, 2017
Corrected
- Owner
- EffRx Pharmaceuticals SA, Dr. med.Yvonne Gunsch-Wegmann, MBA MAS Corporate Finance CFO, Wolleraustrasse 41B, 8807 Freienbach → EffRx Pharmaceuticals SA, Wolleraustrasse 41B, 8807 Freienbach
Published in Swissreg on 03.02.2017
- Mar 22, 2013
Corrected
- Owner
- EffRx Pharmaceuticals SA, Avenue du Théâtre 1, c/o KPMG SA, 1005 Lausanne → EffRx Pharmaceuticals SA, Dr. med.Yvonne Gunsch-Wegmann, MBA MAS Corporate Finance CFO, Wolleraustrasse 41B, 8807 Freienbach
Published in Swissreg on 22.03.2013
- Jan 18, 2012
Granted
Published in Swissreg on 18.01.2012
Parties
Inventor
MCCALLISTER, David
Palm Beach Gardens, FL 33410, US
ROSEN, Christer
Tequesta, FL 33469, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.